Co-Arinate FDC Tablets - 3 Count
Product Overview
Co-Arinate FDC is a fixed-dose combination antimalarial medication used for the effective treatment of acute uncomplicated malaria, especially caused by Plasmodium falciparum. Each tablet contains a synergistic combination of Artesunate and Amodiaquine, delivering a potent, fast-acting, and reliable solution against malaria.
This 3-tablet pack is designed to complete a standard course over 3 days, making it ideal for patient compliance, rapid symptom relief, and parasite clearance.
Key Features
- Active Ingredients: Artesunate and Amodiaquine (fixed-dose combination)
- Formulation: Oral tablets
- Pack Size: 3 tablets (1 tablet per day for 3 days)
- Primary Actions:
- Rapid clearance of malaria parasites from the bloodstream
- Effective treatment of uncomplicated falciparum malaria
- Reduces transmission and likelihood of recurrence
- Dosage: 1 tablet once daily for 3 consecutive days, or as directed by a healthcare provider
Indications
- Treatment of acute uncomplicated malaria caused by P. falciparum
- Effective in areas with documented resistance to older antimalarials
Benefits
- Fast-acting and well-tolerated
- Convenient once-daily dosing for 3 days
- Reduces fever and parasite count quickly
- Effective even in chloroquine-resistant regions
Precautions and Warnings
- Use only under medical supervision, especially in children or pregnant women.
- Not recommended for individuals with known hypersensitivity to artemisinin or amodiaquine derivatives.
- May cause mild side effects such as nausea, dizziness, or fatigue.
- Inform your healthcare provider of any liver problems or other medications being taken.
Storage
- Store below 30°C in a dry place.
- Keep in original packaging to protect from moisture.
- Keep out of reach of children.